Pluri Inc. (NASDAQ:PLUR) short interest fell 33.7% in September

Pluri Inc. (NASDAQ:PLUR – Get Free Report ) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totaling 6,900 shares, a decrease of 33.7% from August 31st’s total of 10,400 shares. Based on an average daily trading volume of 8,000 shares, the days-to-cover ratio is currently 0.9 days. About 0.2% of the company’s shares are short-sold.

Performance of multiple stocks

PLUR stock traded up $0.05 during mid-day trading on Friday, reaching $6.08. The company’s stock had a trading volume of 7,036 shares, compared to its average volume of 12,141. Pluri has a 1 year low of $3.45 and a 1 year high of $8.48. The company has a 50 day simple moving average of $5.49 and a two hundred day simple moving average of $5.74. The company has a current ratio of 6.98, a quick ratio of 6.98, and a debt-to-equity ratio of 4.44. The stock has a market cap of $33.26 million, a P/E ratio of -1.47 and a beta of 1.60.

About Pluri

(Get a free report)

Pluri Inc, a biotechnology company, is engaged in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injury and hematological disorders. It operates in regenerative medicine, food technology and biologics, and is focused on establishing partnerships to use its 3D cell-based technology for additional industries that require mass production of cells.

Featured stories

Get news and reviews for Pluri Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pluri and related companies with MarketBeat.com’s FREE daily email newsletter.